Virtual Reality Analgesia During Pediatric Physical Therapy (VRD/Peds)

March 11, 2019 updated by: David R. Patterson, National Institute of General Medical Sciences (NIGMS)
We would like to determine whether Virtual Reality (VR) analgesia continues to be effective for reducing pain when administered for a clinically relevant treatment duration over multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).

Study Overview

Detailed Description

This study is done in a hospital for inpatients pediatrics. By randomization some subjects will immersive Virtual Reality (VR) during a painful procedure on daily basis up to 10 days to see whether this will reduce the pain and anxiety.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98104-2499
        • Harborview Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age greater than or equal to 8 years up to 20 yrs old
  • Compliant and able to complete subject evaluation
  • A minimum of 3 days of physical therapy, one physical therapy session per day
  • No history of psychiatric (DSM-IV-R Axis I) or developmental disorder that would interfere with decisional capacity
  • Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder that would interfere with decisional capacity
  • Able to communicate verbally
  • Able to take oral medications
  • English-speaking

Exclusion Criteria:

  • - Age less than 8 years, or greater than 20 years.
  • Not capable of indicating pain intensity
  • Not capable of filling out study measures
  • Hospitalization of fewer than 3 days
  • Evidence of traumatic brain injury
  • History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and MD admission notes, if interfering with decisional capacity
  • Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems that would interfere with decisional capacity
  • Unable to communicate verbally
  • Unable to take oral medications
  • History of sig. cardiac, endocrine, neurologic, metabolic, respiratory, gastrointestinal or genitourinary impairment that would interfere with treatment or decisional capacity
  • Receiving prophylaxis for alcohol or drug withdrawal
  • Developmental disability that would interfere with decisional capacity
  • Face/head/neck injuries preventing helmet use
  • Non-English-speaking
  • Extreme susceptibility to motion sickness
  • Seizure history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VR during Physical Therapy
The subject will receive virtual reality during painful physical therapy sessions.
Virtual Reality will be performed during a painful physical therapy procedure.
Experimental: VR background pain
The subjects receives virtual reality, not during a physical therapy procedure, another time of the day for background pain.
Virtual Reality is used at anytime during the day for the background pain, not during physical therapy.
Experimental: No VR
The subject will receive the usual standard treatment. At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.
The subject will receive the usual standard treatment. At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Pain and anxiety
Time Frame: pre and post procedure
pre and post procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David R Patterson, Ph.D., University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2009

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

October 13, 2009

First Submitted That Met QC Criteria

October 13, 2009

First Posted (Estimate)

October 14, 2009

Study Record Updates

Last Update Posted (Actual)

March 13, 2019

Last Update Submitted That Met QC Criteria

March 11, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 36154-C

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burn

Clinical Trials on VR during Physical Therapy

Subscribe